相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial
A. Sattarinezhad et al.
DIABETES & METABOLISM (2019)
Can resveratrol supplement change inflammatory mediators? A systematic review and meta-analysis on randomized clinical trials
Fahimeh Haghighatdoost et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function
Munehiro Kitade et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
The Effect of Resveratrol Supplementation on Cardio-Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double-Blind Controlled Trial
Shima Abdollahi et al.
PHYTOTHERAPY RESEARCH (2019)
Effect of Resveratrol on Blood Lipid Levels in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Hang Zhao et al.
OBESITY (2019)
Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials
S. M. Mousavi et al.
OBESITY REVIEWS (2019)
Impact of resveratrol supplementation on inflammatory, antioxidant, and periodontal markers in type 2 diabetic patients with chronic periodontitis
Ahmad Zare Javid et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
ShadiSadat Seyyedebrahimi et al.
ACTA DIABETOLOGICA (2018)
Resveratrol improves uric acid-induced pancreatic beta-cells injury and dysfunction through regulation of miR-126
Ying Xin et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Resveratrol supplementation decreases blood glucose without changing the circulating CD14+ CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
Hadi Khodabandehloo et al.
NUTRITION RESEARCH (2018)
Resveratrol Inhibits ROS-Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR-21
Bin Yan et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Effect of resveratrol on lipid profile: An updated systematic review and meta-analysis on randomized clinical trials
Fahimeh Haghighatdoost et al.
PHARMACOLOGICAL RESEARCH (2018)
Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Mehdi Koushki et al.
CLINICAL THERAPEUTICS (2018)
Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease
Mitsuo Kato
KIDNEY RESEARCH AND CLINICAL PRACTICE (2018)
C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults
Mohsen Mazidi et al.
ANGIOLOGY (2018)
Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus
Naoko Hashimoto et al.
JOURNAL OF HUMAN GENETICS (2017)
Resveratrol Inhibits Diabetic-Induced Muller Cells Apoptosis through MicroRNA-29b/Specificity Protein 1 Pathway
Kaihong Zeng et al.
MOLECULAR NEUROBIOLOGY (2017)
The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis
Ahmad Zare Javid et al.
PHYTOTHERAPY RESEARCH (2017)
MicroRNA-132 with Therapeutic Potential in Chronic Wounds
Xi Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis
Xiangyun Zhu et al.
NUTRITION & METABOLISM (2017)
MicroRNA-126 suppresses inflammation in endothelial cells under hyperglycemic condition by targeting HMGB1
Song-tao Tang et al.
VASCULAR PHARMACOLOGY (2017)
Resveratrol: from diet to topical usage
Veronica Sanda Chedea et al.
FOOD & FUNCTION (2017)
Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
Min Kyong Moon et al.
DIABETES & METABOLISM JOURNAL (2017)
Resveratrol and diabetes: A critical review of clinical studies
Ebru Ozturk et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
Dimitrios Tsikas
ANALYTICAL BIOCHEMISTRY (2017)
Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy
Shruti Rawal et al.
CARDIOVASCULAR RESEARCH (2017)
Reduced HMGB 1-Mediated Pathway and Oxidative Stress in Resveratrol-Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes Mellitus
Han Wu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
S. Bo et al.
PHARMACOLOGICAL RESEARCH (2016)
Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
Ali Movahed et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease
Joao Tome-Carneiro et al.
PHARMACOLOGICAL RESEARCH (2013)
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Jayesh Kumar Bhatt et al.
NUTRITION RESEARCH (2012)
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria A. Brown et al.
CANCER RESEARCH (2010)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
分享论文
